Covidien PLC (COV)

106.71
1.36 1.26
Prev Close 108.07
Open 107.97
Day Low/High 106.71 / 108.16
52 Wk Low/High 65.97 / 108.57
Volume 24.76M
Avg Volume 3.84M
Exchange
Shares Outstanding 454.51M
Market Cap 48.50B
EPS 3.68
Div & Yield 1.44 (1.30%)

Latest News

Covalon Announces Third Quarter Fiscal 2019 Results

Covalon Announces Third Quarter Fiscal 2019 Results

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its third quarter fiscal 2019 results.

Covalon CEO Provides Corporate Update

Covalon CEO Provides Corporate Update

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, wishes to provide the following corporate update: The team at Covalon continues to make progress in strengthening our business.

Covalon Announces Second Quarter Fiscal 2019 Results

Covalon Announces Second Quarter Fiscal 2019 Results

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV:COV; OTCQX:CVALF), an advanced medical technologies company, today announced its second quarter fiscal 2019 results.

Covalon Announces Conference Call To Discuss Second Quarter Financial Results

Covalon Announces Conference Call To Discuss Second Quarter Financial Results

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will be releasing its Fiscal 2019 Second Quarter financial results on Tuesday May 28 th, 2019, after markets close.

Covalon Announces Voting Results From 2019 Annual And Special Meeting Of Shareholders

Covalon Announces Voting Results From 2019 Annual And Special Meeting Of Shareholders

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV:COV; OTCQX:CVALF), an advanced medical technologies company, today announces the results of the matters voted upon at the Company's 2019 Annual and Special Meeting of Shareholders on held March...

Covalon Announces First Quarter Fiscal 2019 Results And Updates Plans For Fiscal 2019

Covalon Announces First Quarter Fiscal 2019 Results And Updates Plans For Fiscal 2019

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its first quarter fiscal 2019 results and updated its plans for fiscal 2019.

Mr. John Suk Joins Covalon's Board Of Directors

Mr. John Suk Joins Covalon's Board Of Directors

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that Mr.

Dr. Myrna Francis Joins Covalon's Board Of Directors

Dr. Myrna Francis Joins Covalon's Board Of Directors

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that Dr.

Covalon Announces Issuance Of Stock Options

Covalon Announces Issuance Of Stock Options

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announces the issuance of an aggregate of 425,000 stock options to staff of the Company.

Covalon Announces Conference Call To Discuss Year-End And Fourth Quarter Financial Results

Covalon Announces Conference Call To Discuss Year-End And Fourth Quarter Financial Results

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV:COV; OTCQX:CVALF), an advanced medical technologies company, will release its Fiscal 2018 Fourth Quarter and Year-End financial results concurrently on Monday December 17 th, 2018, after markets...

Covalon To Showcase AquaGuard® And IV Clear™ Products To Over 9,000 Nurses At Prestigious ANCC Magnet Conference

Covalon To Showcase AquaGuard® And IV Clear™ Products To Over 9,000 Nurses At Prestigious ANCC Magnet Conference

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV:COV) (OTCQX:CVALF), an advanced medical technologies company, today announces that it will be showcasing newly-acquired moisture barrier line AquaGuard ® as part of its portfolio of infection...

Covalon To Host Conference Call To Discuss Definitive Agreement To Acquire AquaGuard

Covalon To Host Conference Call To Discuss Definitive Agreement To Acquire AquaGuard

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has scheduled a conference call for Friday September 21 st 2018 at 9:00am EST.

Covalon Announces Another Milestone Quarterly Profit On Excellent Third Quarter Financial Results

Covalon Announces Another Milestone Quarterly Profit On Excellent Third Quarter Financial Results

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is pleased to announce today another milestone quarterly profit of $2.

Covalon Announces Receipt Of First Payment Under New License Agreement

Covalon Announces Receipt Of First Payment Under New License Agreement

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it has received $3.

Covalon Announces Major Banking Milestone

Covalon Announces Major Banking Milestone

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that the Company has entered into a new acquisition and operating banking credit facility with HSBC Bank Canada...

Covalon Unaware Of Any Material Change

Covalon Unaware Of Any Material Change

At the request of the Investment Industry Regulatory Organization of Canada ("IIROC"), Covalon Technologies Ltd.

Covalon Announces Retirement Of Member Of Board Of Directors

Covalon Announces Retirement Of Member Of Board Of Directors

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announces that Martin Bernholtz has retired as a member of the Board of Directors of the Company, effective at the end of...

Covalon Technologies Ltd. To Exhibit At The Largest Annual Infection Prevention And Control Conference In The World

Covalon Technologies Ltd. To Exhibit At The Largest Annual Infection Prevention And Control Conference In The World

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it will exhibit at the APIC 2018 Conference in Minneapolis, Minnesota, June 13 th to 15 th.

Covalon Announces Major Corporate Initiatives And Second Quarter Results

Covalon Announces Major Corporate Initiatives And Second Quarter Results

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced some major corporate initiatives and second quarter results.

Covalon To Host Conference Call To Discuss Release Of Q2 Results And Initiatives

Covalon To Host Conference Call To Discuss Release Of Q2 Results And Initiatives

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV:COV; OTCQX:CVALF) an advanced medical technologies company, has scheduled a conference call for Tuesday May 29 th 2018 at 9:00 am ET.

Covalon Announces Major Sales Breakthrough - Wins Contracts With An Estimated Value Of $100 Million Over A Three-Year Period

Covalon Announces Major Sales Breakthrough - Wins Contracts With An Estimated Value Of $100 Million Over A Three-Year Period

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has been informed that it has won a series of competitive contracts in the Middle East with an estimated sales value of $100...

Covalon To Showcase MediClear™ PreOp At AATS 2018 Annual Meeting

Covalon To Showcase MediClear™ PreOp At AATS 2018 Annual Meeting

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it will be showcasing its perioperative suite of innovative products, including MediClear™ PreOp, at the...

Covalon To Feature MediClear™ PreOp At AORN Surgical Conference And Expo 2018

Covalon To Feature MediClear™ PreOp At AORN Surgical Conference And Expo 2018

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it will be featuring its perioperative suite of innovative products including...

Covalon's MediClear™ PreOp Receives Frost & Sullivan's 2018 North American Surgical Site Infection Prevention New Product Innovation Award

Covalon's MediClear™ PreOp Receives Frost & Sullivan's 2018 North American Surgical Site Infection Prevention New Product Innovation Award

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced today its MediClear™ PreOp has received Frost & Sullivan's 2018 North American...

Covalon Announces Its Participation In Medical Japan 2018

Covalon Announces Its Participation In Medical Japan 2018

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it will be participating in the Ontario Government's Life Sciences Trade...

Covalon Announces Strong First Quarter Financial Results

Covalon Announces Strong First Quarter Financial Results

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced today its first quarter financial results.

Covalon Announces Issuance Of Stock Options

Covalon Announces Issuance Of Stock Options

Further to its press release dated October 27, 2017, Covalon Technologies Ltd.

US Major General Gale S. Pollock (Ret.) Joins Covalon's Board Of Directors

US Major General Gale S. Pollock (Ret.) Joins Covalon's Board Of Directors

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is extremely pleased to announce that Major General (Ret.